about
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukem...
Read More
3.17
0.10
(3.26%)
1.1M
XNAS Volume
High vol.+loss this week
XNAS 11 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Lite Strategy Inc. is on 19 Sep 2025 for the purpose of MEI Pharma Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Lite Strategy Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..